Alteration 10101255 ? O
of ? ? O
mannose ? ? I-treatment
transport ? ? O
in ? ? O
fibroblasts ? ? O
from ? ? O
type ? ? I-disease
I ? ? I-disease
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
patients ? ? O
. ? ? O

The 10101255 ? O
aim ? ? O
of ? ? O
the ? ? O
present ? ? O
study ? ? O
was ? ? O
to ? ? O
explore ? ? O
how ? ? O
mannose ? ? I-treatment
enters ? ? O
fibroblasts ? ? O
derived ? ? O
from ? ? O
a ? ? O
panel ? ? O
of ? ? O
children ? ? O
suffering ? ? O
from ? ? O
different ? ? O
subtypes ? ? O
of ? ? O
type ? ? I-disease
I ? ? I-disease
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
: ? ? O
seven ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
subtype ? ? I-disease
Ia ? ? I-disease
( ? ? O
phosphomannomutase ? ? I-disease
deficiency ? ? I-disease
) ? ? O
, ? ? O
two ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
subtype ? ? I-disease
Ib ? ? I-disease
( ? ? O
phosphomannose ? ? I-disease
isomerase ? ? I-disease
deficiency ? ? I-disease
) ? ? O
and ? ? O
two ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
subtype ? ? I-disease
Ix ? ? I-disease
( ? ? O
not ? ? I-disease
identified ? ? I-disease
deficiency ? ? I-disease
) ? ? O
. ? ? O

We 10101255 ? O
showed ? ? O
that ? ? O
a ? ? O
specific ? ? O
mannose ? ? I-treatment
transport ? ? O
system ? ? O
exists ? ? O
in ? ? O
all ? ? O
the ? ? O
cells ? ? O
tested ? ? O
but ? ? O
has ? ? O
different ? ? O
characteristics ? ? O
with ? ? O
respect ? ? O
to ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
subtypes ? ? O
. ? ? O

Subtype 10101255 ? I-disease
Ia ? ? I-disease
fibroblasts ? ? O
presented ? ? O
a ? ? O
mannose ? ? I-treatment
uptake ? ? O
equivalent ? ? O
or ? ? O
higher ? ? O
( ? ? O
maximum ? ? O
1.6-fold ? ? O
) ? ? O
than ? ? O
control ? ? O
cells ? ? O
with ? ? O
a ? ? O
D- ? ? I-treatment
[ ? ? I-treatment
2-3H ? ? I-treatment
] ? ? I-treatment
-mannose ? ? I-treatment
incorporation ? ? O
in ? ? O
nascent ? ? O
N-glycoproteins ? ? I-gene
decreased ? ? O
up ? ? O
to ? ? O
7-fold ? ? O
. ? ? O

Compared 10101255 ? O
to ? ? O
control ? ? O
cells ? ? O
, ? ? O
the ? ? O
mannose ? ? I-treatment
uptake ? ? O
was ? ? O
greatly ? ? O
stimulated ? ? O
in ? ? O
subtype ? ? I-disease
Ib ? ? I-disease
( ? ? O
4.0-fold ? ? O
) ? ? O
, ? ? O
due ? ? O
to ? ? O
lower ? ? O
Kuptake ? ? O
and ? ? O
higher ? ? O
Vmax ? ? O
values ? ? O
. ? ? O

Subtype 10101255 ? I-disease
Ib ? ? I-disease
cells ? ? O
showed ? ? O
an ? ? O
increased ? ? O
incorporation ? ? O
of ? ? O
D- ? ? I-treatment
[ ? ? I-treatment
2-3H ? ? I-treatment
] ? ? I-treatment
-mannose ? ? I-treatment
into ? ? O
nascent ? ? O
N-glycoproteins ? ? I-gene
. ? ? O

Subtype 10101255 ? I-disease
Ix ? ? I-disease
fibroblasts ? ? O
presented ? ? O
an ? ? O
intermediary ? ? O
status ? ? O
with ? ? O
mannose ? ? I-treatment
uptake ? ? O
equivalent ? ? O
to ? ? O
the ? ? O
control ? ? O
but ? ? O
with ? ? O
an ? ? O
increased ? ? O
incorporation ? ? O
of ? ? O
D- ? ? I-treatment
[ ? ? I-treatment
2-3H ? ? I-treatment
] ? ? I-treatment
-mannose ? ? I-treatment
in ? ? O
nascent ? ? O
N-glycoproteins ? ? I-gene
. ? ? O

All 10101255 ? O
together ? ? O
, ? ? O
our ? ? O
results ? ? O
demonstrate ? ? O
quantitative ? ? O
and ? ? O
/ ? ? O
or ? ? O
qualitative ? ? O
modifications ? ? O
in ? ? O
mannose ? ? I-treatment
transport ? ? O
of ? ? O
all ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
fibroblasts ? ? O
in ? ? O
comparison ? ? O
to ? ? O
control ? ? O
cells ? ? O
, ? ? O
with ? ? O
a ? ? O
relative ? ? O
homogeneity ? ? O
within ? ? O
a ? ? O
considered ? ? O
subtype ? ? O
of ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
. ? ? O

These 10101255 ? O
results ? ? O
are ? ? O
consistent ? ? O
with ? ? O
the ? ? O
possible ? ? O
use ? ? O
of ? ? O
mannose ? ? I-treatment
as ? ? O
a ? ? O
therapeutic ? ? O
agent ? ? O
in ? ? O
carbohydrate ? ? I-disease
deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
Ib ? ? I-disease
and ? ? I-disease
Ix ? ? I-disease
. ? ? O

Carbohydrate-deficient 10571009 ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
IA ? ? I-disease
( ? ? O
phosphomannomutase-deficiency ? ? I-disease
) ? ? O
. ? ? O

The 10571009 ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
or ? ? I-disease
CDG ? ? I-disease
syndromes ? ? I-disease
( ? ? O
OMIM ? ? I-disease
212065 ? ? I-disease
) ? ? O
are ? ? O
a ? ? O
recently ? ? O
delineated ? ? O
group ? ? O
of ? ? O
genetic ? ? O
, ? ? O
multisystem ? ? O
diseases ? ? O
with ? ? O
variable ? ? O
dysmorphic ? ? I-disease
features ? ? I-disease
. ? ? O

The 10571009 ? O
known ? ? O
CDG ? ? I-disease
syndromes ? ? O
are ? ? O
characterized ? ? O
by ? ? O
a ? ? O
partial ? ? I-disease
deficiency ? ? I-disease
of ? ? I-disease
the ? ? I-disease
N-linked ? ? I-disease
glycans ? ? I-disease
of ? ? I-disease
secretory ? ? I-disease
glycoproteins ? ? I-disease
, ? ? I-disease
lysosomal ? ? I-disease
enzymes ? ? I-disease
, ? ? I-disease
and ? ? I-disease
probably ? ? I-disease
also ? ? I-disease
membranous ? ? I-disease
glycoproteins ? ? I-disease
. ? ? O

Due 10571009 ? O
to ? ? O
the ? ? O
deficiency ? ? I-disease
of ? ? I-disease
terminal ? ? I-disease
N-acetylneuraminic ? ? I-disease
acid ? ? I-disease
or ? ? I-disease
sialic ? ? I-disease
acid ? ? I-disease
, ? ? O
the ? ? O
glycan ? ? I-disease
changes ? ? I-disease
can ? ? O
be ? ? O
observed ? ? O
in ? ? O
serum ? ? O
transferrin ? ? O
or ? ? O
other ? ? O
glycoproteins ? ? O
using ? ? O
isoelectrofocusing ? ? O
with ? ? O
immunofixation ? ? O
as ? ? O
the ? ? O
most ? ? O
widely ? ? O
used ? ? O
diagnostic ? ? O
technique ? ? O
. ? ? O

Most 10571009 ? O
patients ? ? O
show ? ? O
a ? ? O
serum ? ? O
sialotransferrin ? ? O
pattern ? ? O
characterized ? ? O
by ? ? O
increased ? ? I-disease
di- ? ? I-disease
and ? ? I-disease
asialotransferrin ? ? I-disease
bands ? ? I-disease
( ? ? O
type ? ? I-disease
I ? ? I-disease
pattern ? ? I-disease
) ? ? O
. ? ? O

The 10571009 ? O
majority ? ? O
of ? ? O
patients ? ? O
with ? ? O
type ? ? I-disease
I ? ? I-disease
are ? ? O
phosphomannomutase ? ? I-disease
deficient ? ? I-disease
( ? ? O
type ? ? I-disease
IA ? ? I-disease
) ? ? O
, ? ? O
while ? ? O
in ? ? O
a ? ? O
few ? ? O
other ? ? O
patients ? ? O
, ? ? O
deficiencies ? ? I-disease
of ? ? I-disease
phosphomannose ? ? I-disease
isomerase ? ? I-disease
( ? ? O
type ? ? I-disease
IB ? ? I-disease
) ? ? O
or ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
glucosyltransferase ? ? I-disease
( ? ? O
type ? ? I-disease
IC ? ? I-disease
) ? ? O
have ? ? O
been ? ? O
demonstrated ? ? O
. ? ? O

This 10571009 ? O
review ? ? O
is ? ? O
an ? ? O
update ? ? O
on ? ? O
CDG ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
IA ? ? I-disease
. ? ? O

Mutations 11058895 ? O
in ? ? O
PMM2 ? ? I-gene
that ? ? O
cause ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
, ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
. ? ? O

The 11058895 ? O
PMM2 ? ? I-gene
gene ? ? O
, ? ? O
which ? ? O
is ? ? O
defective ? ? O
in ? ? O
CDG-Ia ? ? I-disease
, ? ? O
was ? ? O
cloned ? ? O
three ? ? O
years ? ? O
ago ? ? O
[ ? ? O
Matthijs ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1997b ? ? O
] ? ? O
. ? ? O

Several 11058895 ? O
publications ? ? O
list ? ? O
PMM2 ? ? I-gene
mutations ? ? O
[ ? ? O
Matthijs ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1997b ? ? O
, ? ? O
1998 ? ? O
; ? ? O
Kjaergaard ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1998 ? ? O
, ? ? O
1999 ? ? O
; ? ? O
Bjursell ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1998 ? ? O
, ? ? O
2000 ? ? O
; ? ? O
Imtiaz ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
2000 ? ? O
] ? ? O
and ? ? O
a ? ? O
few ? ? O
mutations ? ? O
have ? ? O
appeared ? ? O
in ? ? O
case ? ? O
reports ? ? O
or ? ? O
abstracts ? ? O
[ ? ? O
Crosby ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1999 ? ? O
; ? ? O
Kondo ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1999 ? ? O
; ? ? O
Krasnewich ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1999 ? ? O
; ? ? O
Mizugishi ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1999 ? ? O
; ? ? O
Vuillaumier-Barrot ? ? O
et ? ? O
al. ? ? O

, 11058895 ? O
1999 ? ? O
, ? ? O
2000b ? ? O
] ? ? O
. ? ? O

However 11058895 ? O
, ? ? O
the ? ? O
number ? ? O
of ? ? O
molecularly ? ? O
characterized ? ? O
cases ? ? O
is ? ? O
steadily ? ? O
increasing ? ? O
and ? ? O
many ? ? O
new ? ? O
mutations ? ? O
may ? ? O
never ? ? O
make ? ? O
it ? ? O
to ? ? O
the ? ? O
literature ? ? O
. ? ? O

Therefore 11058895 ? O
, ? ? O
we ? ? O
decided ? ? O
to ? ? O
collate ? ? O
data ? ? O
from ? ? O
six ? ? O
research ? ? O
and ? ? O
diagnostic ? ? O
laboratories ? ? O
that ? ? O
have ? ? O
committed ? ? O
themselves ? ? O
to ? ? O
a ? ? O
systematic ? ? O
search ? ? O
for ? ? O
PMM2 ? ? I-gene
mutations ? ? O
. ? ? O

In 11058895 ? O
total ? ? O
we ? ? O
list ? ? O
58 ? ? O
different ? ? O
mutations ? ? O
found ? ? O
in ? ? O
249 ? ? O
patients ? ? O
from ? ? O
23 ? ? O
countries ? ? O
. ? ? O

We 11058895 ? O
have ? ? O
also ? ? O
collected ? ? O
demographic ? ? O
data ? ? O
and ? ? O
registered ? ? O
the ? ? O
number ? ? O
of ? ? O
deceased ? ? O
patients ? ? O
. ? ? O

The 11058895 ? O
documentation ? ? O
of ? ? O
the ? ? O
genotype-phenotype ? ? O
correlation ? ? O
is ? ? O
certainly ? ? O
valuable ? ? O
, ? ? O
but ? ? O
is ? ? O
out ? ? O
of ? ? O
the ? ? O
scope ? ? O
of ? ? O
this ? ? O
molecular ? ? O
update ? ? O
. ? ? O

The 11058895 ? O
list ? ? O
of ? ? O
mutations ? ? O
will ? ? O
also ? ? O
be ? ? O
available ? ? O
online ? ? O
( ? ? O
URL ? ? O
: ? ? O
http ? ? O
: ? ? O
/ ? ? O
/ ? ? O
www.kuleuven ? ? O
. ? ? O

ac.be 11058895 ? O
/ ? ? O
med ? ? O
/ ? ? O
cdg ? ? O
) ? ? O
and ? ? O
investigators ? ? O
are ? ? O
invited ? ? O
to ? ? O
submit ? ? O
new ? ? O
data ? ? O
to ? ? O
this ? ? O
PMM2 ? ? I-gene
mutation ? ? O
database ? ? O
. ? ? O

Autosomal 11860984 ? I-disease
recessive ? ? I-disease
cerebellar ? ? I-disease
ataxia ? ? I-disease
with ? ? O
bull's-eye ? ? I-disease
macular ? ? I-disease
dystrophy ? ? I-disease
. ? ? O

PURPOSE 11860984 ? O
: ? ? O
In ? ? O
1980 ? ? O
, ? ? O
we ? ? O
published ? ? O
in ? ? O
the ? ? O
American ? ? O
Journal ? ? O
of ? ? O
Ophthalmology ? ? O
two ? ? O
siblings ? ? O
with ? ? O
hereditary ? ? I-disease
ataxia ? ? I-disease
and ? ? O
atrophic ? ? I-disease
maculopathy ? ? I-disease
. ? ? O

The 11860984 ? O
report ? ? O
is ? ? O
cited ? ? O
in ? ? O
the ? ? O
literature ? ? O
as ? ? O
autosomal ? ? I-disease
dominant ? ? I-disease
cerebellar ? ? I-disease
ataxia ? ? I-disease
with ? ? O
retinal ? ? I-disease
degeneration ? ? I-disease
. ? ? O

The 11860984 ? O
purpose ? ? O
of ? ? O
the ? ? O
present ? ? O
study ? ? O
is ? ? O
to ? ? O
document ? ? O
the ? ? O
progression ? ? O
of ? ? O
the ? ? O
neurodegenerative ? ? I-disease
disorder ? ? I-disease
and ? ? O
to ? ? O
review ? ? O
the ? ? O
diagnosis ? ? O
. ? ? O

DESIGN 11860984 ? O
: ? ? O
Observational ? ? O
case ? ? O
report ? ? O
. ? ? O

METHODS 11860984 ? O
: ? ? O
Twenty ? ? O
years ? ? O
after ? ? O
the ? ? O
original ? ? O
publication ? ? O
, ? ? O
the ? ? O
52-year-old ? ? O
male ? ? O
patient ? ? O
had ? ? O
new ? ? O
ocular ? ? O
and ? ? O
neurologic ? ? O
examinations ? ? O
, ? ? O
fluorescein ? ? O
angiography ? ? O
, ? ? O
molecular ? ? O
genetic ? ? O
analysis ? ? O
, ? ? O
and ? ? O
biochemical ? ? O
testing ? ? O
. ? ? O

RESULTS 11860984 ? O
: ? ? O
Fluorescein ? ? O
angiography ? ? O
showed ? ? O
marked ? ? O
progression ? ? O
of ? ? O
the ? ? O
macular ? ? I-disease
dystrophy ? ? I-disease
to ? ? O
a ? ? O
bull's-eye ? ? O
configuration ? ? O
. ? ? O

Genetic 11860984 ? O
analysis ? ? O
of ? ? O
the ? ? O
patient ? ? O
did ? ? O
not ? ? O
show ? ? O
CAG ? ? I-gene
trinucleotide ? ? I-gene
repeat ? ? I-gene
expansion ? ? I-gene
in ? ? O
the ? ? O
various ? ? O
spinocerebellar ? ? I-disease
ataxia ? ? I-disease
genes ? ? O
. ? ? O

This 11860984 ? O
excludes ? ? O
the ? ? O
diagnosis ? ? O
of ? ? O
autosomal ? ? I-disease
dominant ? ? I-disease
cerebellar ? ? I-disease
ataxia ? ? I-disease
with ? ? O
macular ? ? I-disease
degeneration ? ? I-disease
( ? ? O
ADCA ? ? I-disease
type ? ? I-disease
II ? ? I-disease
) ? ? O
with ? ? O
mutation ? ? O
of ? ? O
the ? ? O
spinocerebellar ? ? I-gene
ataxia ? ? I-gene
7 ? ? I-gene
gene ? ? O
. ? ? O

Major 11860984 ? O
causes ? ? O
of ? ? O
autosomal ? ? I-disease
recessive ? ? I-disease
cerebellar ? ? I-disease
ataxia ? ? I-disease
with ? ? O
retinal ? ? I-disease
degeneration ? ? I-disease
, ? ? O
including ? ? O
Friedreich ? ? I-disease
ataxia ? ? I-disease
and ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
, ? ? O
were ? ? O
also ? ? O
excluded ? ? O
. ? ? O

CONCLUSION 11860984 ? O
: ? ? O
The ? ? O
two ? ? O
patients ? ? O
, ? ? O
previously ? ? O
published ? ? O
in ? ? O
the ? ? O
American ? ? O
Journal ? ? O
of ? ? O
Ophthalmology ? ? O
by ? ? O
Eerola ? ? O
and ? ? O
coworkers ? ? O
, ? ? O
did ? ? O
not ? ? O
suffer ? ? O
from ? ? O
presently ? ? O
recognized ? ? O
disorders ? ? O
with ? ? O
cerebellar ? ? I-disease
ataxia ? ? I-disease
and ? ? O
retinal ? ? I-disease
degeneration ? ? I-disease
. ? ? O

The 11860984 ? O
Eerola ? ? O
syndrome ? ? O
probably ? ? O
represents ? ? O
a ? ? O
separate ? ? O
neurodegenerative ? ? I-disease
entity ? ? I-disease
characterized ? ? O
by ? ? O
autosomal ? ? I-disease
recessive ? ? I-disease
cerebellar ? ? I-disease
ataxia ? ? I-disease
and ? ? O
progressive ? ? O
macular ? ? I-disease
dystrophy ? ? I-disease
with ? ? I-disease
a ? ? I-disease
bull's-eye ? ? I-disease
pattern ? ? I-disease
. ? ? O

Carbohydrate-deficient 11885720 ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
1b ? ? I-disease
: ? ? O
a ? ? O
new ? ? O
answer ? ? O
to ? ? O
an ? ? O
old ? ? O
diagnostic ? ? O
dilemma ? ? O
. ? ? O

A 11885720 ? O
patient ? ? O
with ? ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
1b ? ? I-disease
( ? ? O
CDGS1b ? ? I-disease
) ? ? O
is ? ? O
reported ? ? O
. ? ? O

The 11885720 ? O
patient ? ? O
presented ? ? O
at ? ? O
5 ? ? O
months ? ? O
of ? ? O
age ? ? O
with ? ? O
failure ? ? I-disease
to ? ? I-disease
thrive ? ? I-disease
, ? ? O
prolonged ? ? I-disease
diarrhoea ? ? I-disease
, ? ? O
hepatomegaly ? ? I-disease
and ? ? O
elevated ? ? I-disease
serum ? ? I-disease
liver ? ? I-disease
transaminases ? ? I-disease
. ? ? O

Liver 11885720 ? O
biopsy ? ? O
showed ? ? O
steatosis ? ? I-disease
. ? ? O

A 11885720 ? O
low ? ? I-disease
serum ? ? I-disease
albumin ? ? I-disease
and ? ? O
elevated ? ? I-disease
serum ? ? I-disease
liver ? ? I-disease
transaminases ? ? I-disease
persisted ? ? O
throughout ? ? O
childhood ? ? O
during ? ? O
which ? ? O
he ? ? O
had ? ? O
repeated ? ? O
infectious ? ? I-disease
illnesses ? ? I-disease
. ? ? O

From 11885720 ? O
the ? ? O
age ? ? O
of ? ? O
10 ? ? O
years ? ? O
he ? ? O
had ? ? O
oesophageal ? ? I-disease
and ? ? I-disease
duodenal ? ? I-disease
ulceration ? ? I-disease
together ? ? O
with ? ? O
recurrent ? ? I-disease
bacterial ? ? I-disease
cholangitis ? ? I-disease
. ? ? O

Liver 11885720 ? O
biopsy ? ? O
demonstrated ? ? O
hepatic ? ? I-disease
fibrosis ? ? I-disease
. ? ? O

CDGS1b 11885720 ? I-disease
was ? ? O
suspected ? ? O
, ? ? O
supported ? ? O
by ? ? O
the ? ? O
finding ? ? O
of ? ? O
a ? ? O
protein-losing ? ? I-disease
enteropathy ? ? I-disease
and ? ? O
finally ? ? O
confirmed ? ? O
by ? ? O
showing ? ? O
a ? ? O
reduced ? ? I-disease
phosphomannoseisomerase ? ? I-disease
activity ? ? I-disease
. ? ? O

This 11885720 ? O
case ? ? O
illustrates ? ? O
a ? ? O
rare ? ? O
condition ? ? O
with ? ? O
a ? ? O
wide ? ? O
range ? ? O
of ? ? O
presentations ? ? O
. ? ? O

Prepubertal 12244009 ? O
growth ? ? O
in ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
. ? ? O

AIMS 12244009 ? O
: ? ? O
To ? ? O
delineate ? ? O
the ? ? O
pattern ? ? O
of ? ? O
growth ? ? O
in ? ? O
prepubertal ? ? O
children ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
in ? ? O
order ? ? O
to ? ? O
identify ? ? O
critical ? ? O
period ? ? O
( ? ? O
s ? ? O
) ? ? O
and ? ? O
possible ? ? O
cause ? ? O
( ? ? O
s ? ? O
) ? ? O
of ? ? O
growth ? ? I-disease
failure ? ? I-disease
. ? ? O

METHODS 12244009 ? O
: ? ? O
Longitudinal ? ? O
measurements ? ? O
of ? ? O
weight ? ? O
, ? ? O
length ? ? O
/ ? ? O
height ? ? O
, ? ? O
and ? ? O
head ? ? O
circumference ? ? O
from ? ? O
birth ? ? O
to ? ? O
10 ? ? O
years ? ? O
of ? ? O
age ? ? O
in ? ? O
25 ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
with ? ? O
the ? ? O
R141H ? ? I-gene
/ ? ? I-gene
F119L ? ? I-gene
PMM2 ? ? I-gene
genotype ? ? O
were ? ? O
analysed ? ? O
. ? ? O

The 12244009 ? O
data ? ? O
and ? ? O
derived ? ? O
body ? ? O
mass ? ? O
indices ? ? O
( ? ? O
BMI ? ? O
) ? ? O
were ? ? O
compared ? ? O
with ? ? O
standards ? ? O
and ? ? O
expressed ? ? O
as ? ? O
standard ? ? O
deviation ? ? O
scores ? ? O
( ? ? O
SDS ? ? O
) ? ? O
. ? ? O

A 12244009 ? O
linear ? ? O
mixed ? ? O
effects ? ? O
model ? ? O
was ? ? O
fitted ? ? O
to ? ? O
each ? ? O
set ? ? O
of ? ? O
data ? ? O
, ? ? O
and ? ? O
mean ? ? O
curves ? ? O
were ? ? O
estimated ? ? O
. ? ? O

RESULTS 12244009 ? O
: ? ? O
The ? ? O
mean ? ? O
weight ? ? O
SDS ? ? O
decreased ? ? O
from ? ? O
-0.3 ? ? O
at ? ? O
birth ? ? O
to ? ? O
-3.0 ? ? O
at ? ? O
7 ? ? O
months ? ? O
of ? ? O
age ? ? O
and ? ? O
remained ? ? O
low ? ? O
or ? ? O
increased ? ? O
slightly ? ? O
. ? ? O

The 12244009 ? O
mean ? ? O
length ? ? O
SDS ? ? O
decreased ? ? O
from ? ? O
zero ? ? O
at ? ? O
birth ? ? O
to ? ? O
-2.4 ? ? O
at ? ? O
7 ? ? O
months ? ? O
of ? ? O
age ? ? O
followed ? ? O
by ? ? O
a ? ? O
slight ? ? O
increase ? ? O
to ? ? O
a ? ? O
maximum ? ? O
of ? ? O
-1.8 ? ? O
SDS ? ? O
at ? ? O
the ? ? O
end ? ? O
of ? ? O
the ? ? O
second ? ? O
year ? ? O
of ? ? O
life ? ? O
. ? ? O

After 12244009 ? O
age ? ? O
2 ? ? O
the ? ? O
mean ? ? O
length ? ? O
/ ? ? O
height ? ? O
SDS ? ? O
decreased ? ? O
again ? ? O
. ? ? O

The 12244009 ? O
mean ? ? O
BMI ? ? O
SDS ? ? O
at ? ? O
birth ? ? O
was ? ? O
-0.7 ? ? O
and ? ? O
declined ? ? O
to ? ? O
a ? ? O
minimum ? ? O
of ? ? O
-2.8 ? ? O
at ? ? O
the ? ? O
end ? ? O
of ? ? O
the ? ? O
second ? ? O
year ? ? O
of ? ? O
life ? ? O
followed ? ? O
by ? ? O
a ? ? O
gradual ? ? O
increase ? ? O
. ? ? O

The 12244009 ? O
mean ? ? O
head ? ? O
circumference ? ? O
SDS ? ? O
declined ? ? O
gradually ? ? O
from ? ? O
0 ? ? O
at ? ? O
3 ? ? O
months ? ? O
of ? ? O
age ? ? O
to ? ? O
-1.9 ? ? O
at ? ? O
age ? ? O
5 ? ? O
. ? ? O

CONCLUSION 12244009 ? O
: ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
with ? ? O
the ? ? O
R141H ? ? I-gene
/ ? ? I-gene
F119L ? ? I-gene
genotype ? ? O
have ? ? O
normal ? ? O
fetal ? ? I-disease
growth ? ? I-disease
and ? ? O
an ? ? O
immediate ? ? O
postnatal ? ? O
onset ? ? O
of ? ? O
severe ? ? I-disease
growth ? ? I-disease
failure ? ? I-disease
. ? ? O

A 12244009 ? O
notable ? ? O
decline ? ? I-disease
in ? ? I-disease
weight ? ? I-disease
end ? ? O
length ? ? O
SDS ? ? O
takes ? ? O
place ? ? O
during ? ? O
the ? ? O
first ? ? O
seven ? ? O
months ? ? O
of ? ? O
life ? ? O
with ? ? O
no ? ? O
prepubertal ? ? O
catch ? ? O
up ? ? O
. ? ? O

Severe 12297897 ? O
transient ? ? O
myocardial ? ? I-disease
ischaemia ? ? I-disease
caused ? ? O
by ? ? O
hypertrophic ? ? I-disease
cardiomyopathy ? ? I-disease
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

Severely 12297897 ? O
affected ? ? O
children ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
; ? ? O
MIM ? ? I-treatment
212065 ? ? I-treatment
) ? ? O
may ? ? O
develop ? ? O
hypertrophic ? ? I-disease
cardiomyopathy ? ? I-disease
. ? ? O

In 12297897 ? O
this ? ? O
report ? ? O
we ? ? O
describe ? ? O
the ? ? O
near-death ? ? O
of ? ? O
a ? ? O
10-month-old ? ? O
girl ? ? O
with ? ? O
CDG-Ia ? ? I-disease
due ? ? O
to ? ? O
acute ? ? O
left-ventricular ? ? I-disease
outlet ? ? I-disease
obstruction ? ? I-disease
caused ? ? O
by ? ? O
hypertrophic ? ? I-disease
cardiomyopathy ? ? I-disease
and ? ? O
acute ? ? O
dehydration ? ? I-disease
. ? ? O

The 12297897 ? O
girl ? ? O
had ? ? O
multi-organ ? ? I-disease
failure ? ? I-disease
and ? ? O
signs ? ? O
of ? ? O
severe ? ? I-disease
myocardial ? ? I-disease
damage ? ? I-disease
mimicking ? ? O
myocardial ? ? I-disease
infarction ? ? I-disease
. ? ? O

CONCLUSION 12297897 ? O
: ? ? O
hypertrophic ? ? I-disease
cardiomyopathy ? ? I-disease
contributes ? ? O
to ? ? O
the ? ? O
high ? ? O
mortality ? ? O
of ? ? O
young ? ? O
children ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

Even 12297897 ? O
if ? ? O
cardiomyopathy ? ? I-disease
in ? ? O
this ? ? O
disease ? ? O
is ? ? O
non-obstructive ? ? O
, ? ? O
acute ? ? O
fluid-loss ? ? O
might ? ? O
cause ? ? O
left ? ? I-disease
ventricular ? ? I-disease
outflow ? ? I-disease
tract ? ? I-disease
obstruction ? ? I-disease
and ? ? O
life-threatening ? ? O
myocardial ? ? I-disease
ischaemia ? ? I-disease
. ? ? O

Patients 12297897 ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
are ? ? O
at ? ? O
risk ? ? O
for ? ? O
cardiac ? ? I-disease
complications ? ? I-disease
and ? ? O
should ? ? O
be ? ? O
monitored ? ? O
regularly ? ? O
by ? ? O
echocardiography ? ? O
. ? ? O

Ophthalmic 12789572 ? I-disease
manifestations ? ? I-disease
of ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
1a ? ? I-disease
. ? ? O

PURPOSE 12789572 ? O
: ? ? O
To ? ? O
present ? ? O
the ? ? O
ophthalmic ? ? I-disease
manifestations ? ? I-disease
of ? ? O
patients ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
due ? ? O
to ? ? O
the ? ? O
frequent ? ? O
R141H ? ? I-gene
/ ? ? I-gene
F119L ? ? I-gene
PMM2 ? ? I-gene
genotype ? ? O
. ? ? O

METHODS 12789572 ? O
: ? ? O
Ophthalmic ? ? O
records ? ? O
of ? ? O
23 ? ? O
patients ? ? O
( ? ? O
age ? ? O
: ? ? O
10 ? ? O
months ? ? O
to ? ? O
20 ? ? O
years ? ? O
) ? ? O
were ? ? O
evaluated ? ? O
. ? ? O

They 12789572 ? O
had ? ? O
had ? ? O
at ? ? O
least ? ? O
one ? ? O
ophthalmic ? ? O
reexamination ? ? O
. ? ? O

RESULTS 12789572 ? O
: ? ? O
Measurements ? ? O
of ? ? O
refractive ? ? I-disease
error ? ? I-disease
showed ? ? O
that ? ? O
18 ? ? O
patients ? ? O
were ? ? O
myopic ? ? I-disease
, ? ? O
two ? ? O
were ? ? O
hypermetropic ? ? I-disease
, ? ? O
and ? ? O
three ? ? O
could ? ? O
not ? ? O
be ? ? O
measured ? ? O
. ? ? O

Serial 12789572 ? O
measurements ? ? O
in ? ? O
12 ? ? O
patients ? ? O
indicated ? ? O
a ? ? O
progression ? ? O
towards ? ? O
myopia ? ? I-disease
of ? ? O
0.80 ? ? O
diopters ? ? O
( ? ? O
D ? ? O
) ? ? O
per ? ? O
year ? ? O
. ? ? O

Congenital 12789572 ? I-disease
esotropia ? ? I-disease
and ? ? O
delayed ? ? I-disease
visual ? ? I-disease
maturation ? ? I-disease
( ? ? O
DVM ? ? I-disease
) ? ? O
were ? ? O
consistent ? ? O
findings ? ? O
. ? ? O

Two 12789572 ? O
children ? ? O
developed ? ? O
good ? ? I-disease
visual ? ? I-disease
acuity ? ? I-disease
( ? ? O
VA ? ? I-disease
) ? ? O
, ? ? O
16 ? ? O
had ? ? O
low ? ? I-disease
vision ? ? I-disease
, ? ? O
and ? ? O
five ? ? O
were ? ? O
legally ? ? I-disease
blind ? ? I-disease
. ? ? O

Pallor 12789572 ? I-disease
of ? ? I-disease
the ? ? I-disease
optic ? ? I-disease
disc ? ? I-disease
was ? ? O
noted ? ? O
in ? ? O
five ? ? O
patients ? ? O
. ? ? O

Electroretinography 12789572 ? O
( ? ? O
ERG ? ? O
) ? ? O
performed ? ? O
in ? ? O
nine ? ? O
patients ? ? O
showed ? ? O
reduced ? ? I-disease
rod ? ? I-disease
responses ? ? I-disease
, ? ? O
while ? ? O
cone ? ? O
responses ? ? O
were ? ? O
only ? ? O
slightly ? ? O
reduced ? ? O
. ? ? O

CONCLUSIONS 12789572 ? O
: ? ? O
The ? ? O
present ? ? O
study ? ? O
illustrates ? ? O
the ? ? O
difficulties ? ? O
in ? ? O
examining ? ? O
severely ? ? O
disabled ? ? O
children ? ? O
. ? ? O

Consistent 12789572 ? O
ophthalmic ? ? I-disease
manifestations ? ? I-disease
of ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
due ? ? O
to ? ? O
the ? ? O
R141H ? ? I-gene
/ ? ? I-gene
F119L ? ? I-gene
genotype ? ? O
were ? ? O
congenital ? ? I-disease
esotropia ? ? I-disease
, ? ? O
DVM ? ? I-disease
, ? ? O
and ? ? O
a ? ? O
reduced ? ? I-disease
rod ? ? I-disease
response ? ? I-disease
in ? ? O
ERG-examined ? ? O
patients ? ? O
. ? ? O

The 12789572 ? O
vast ? ? O
majority ? ? O
of ? ? O
patients ? ? O
had ? ? O
reduced ? ? I-disease
VA ? ? I-disease
and ? ? O
developed ? ? O
myopia ? ? I-disease
. ? ? O

We 12789572 ? O
speculate ? ? O
that ? ? O
there ? ? O
is ? ? O
a ? ? O
relationship ? ? O
between ? ? O
the ? ? O
glycosylation ? ? I-disease
defect ? ? I-disease
in ? ? O
CDG-Ia ? ? I-disease
and ? ? O
the ? ? O
development ? ? O
of ? ? O
myopia ? ? I-disease
. ? ? O

We 12789572 ? O
recommend ? ? O
that ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
be ? ? O
followed ? ? O
annually ? ? O
by ? ? O
an ? ? O
ophthalmologist ? ? O
. ? ? O

Carbohydrate-deficient 15205047 ? O
transferrin ? ? O
( ? ? O
CDT ? ? O
) ? ? O
-- ? ? O
a ? ? O
biomarker ? ? O
for ? ? O
long-term ? ? O
alcohol ? ? O
consumption ? ? O
. ? ? O

Carbohydrate-deficient 15205047 ? O
transferrin ? ? O
( ? ? O
CDT ? ? O
) ? ? O
is ? ? O
a ? ? O
biomarker ? ? O
for ? ? O
chronic ? ? O
alcohol ? ? O
intake ? ? O
of ? ? O
more ? ? O
than ? ? O
60 ? ? O
g ? ? O
ethanol ? ? O
/ ? ? O
d. ? ? O
It ? ? O
has ? ? O
been ? ? O
reported ? ? O
to ? ? O
be ? ? O
superior ? ? O
to ? ? O
conventional ? ? O
markers ? ? O
like ? ? O
gamma-glutamyltransferase ? ? O
( ? ? O
GGT ? ? O
) ? ? O
and ? ? O
mean ? ? O
corpuscular ? ? O
volume ? ? O
MCV ? ? O
) ? ? O
. ? ? O

This 15205047 ? O
review ? ? O
covers ? ? O
theoretical ? ? O
and ? ? O
analytical ? ? O
aspects ? ? O
, ? ? O
with ? ? O
data ? ? O
from ? ? O
controlled ? ? O
drinking ? ? O
experiments ? ? O
and ? ? O
from ? ? O
different ? ? O
population ? ? O
subgroups ? ? O
such ? ? O
as ? ? O
subjects ? ? O
with ? ? O
different ? ? O
liver ? ? I-disease
diseases ? ? I-disease
or ? ? O
different ? ? O
drinking ? ? O
patterns ? ? O
. ? ? O

CDT 15205047 ? O
determinations ? ? O
are ? ? O
particularly ? ? O
indicated ? ? O
in ? ? O
( ? ? O
1 ? ? O
) ? ? O
cases ? ? O
of ? ? O
chronic ? ? O
alcohol ? ? O
consumption ? ? O
and ? ? O
relapses ? ? O
after ? ? O
withdrawal ? ? O
, ? ? O
( ? ? O
2 ? ? O
) ? ? O
license ? ? O
reapplication ? ? O
after ? ? O
driving ? ? O
under ? ? O
alcohol ? ? O
influence ? ? O
, ? ? O
( ? ? O
3 ? ? O
) ? ? O
differentiating ? ? O
patients ? ? O
with ? ? O
enzyme-inducing ? ? O
medication ? ? O
from ? ? O
those ? ? O
with ? ? O
alcohol ? ? I-disease
abuse ? ? I-disease
, ? ? O
4 ? ? O
) ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
such ? ? O
as ? ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDGS ? ? I-disease
Ia ? ? I-disease
) ? ? O
, ? ? O
and ? ? O
( ? ? O
5 ? ? O
) ? ? O
patients ? ? O
treated ? ? O
for ? ? O
galactosemia ? ? I-disease
. ? ? O

The 15205047 ? O
main ? ? O
advantage ? ? O
of ? ? O
CDT ? ? O
is ? ? O
its ? ? O
high ? ? O
specificity ? ? O
, ? ? O
as ? ? O
evidenced ? ? O
in ? ? O
combination ? ? O
with ? ? O
increased ? ? O
alcohol ? ? O
consumption ? ? O
. ? ? O

CDT 15205047 ? O
values ? ? O
are ? ? O
not ? ? O
markedly ? ? O
influenced ? ? O
by ? ? O
medication ? ? O
except ? ? O
in ? ? O
immunosuppressed ? ? O
patients ? ? O
, ? ? O
who ? ? O
may ? ? O
show ? ? O
low ? ? O
CDT ? ? O
values ? ? O
. ? ? O

In 15205047 ? O
general ? ? O
, ? ? O
CDT ? ? O
values ? ? O
appear ? ? O
less ? ? O
elevated ? ? O
after ? ? O
alcohol ? ? O
intake ? ? O
in ? ? O
women ? ? O
. ? ? O

The 15205047 ? O
main ? ? O
disadvantage ? ? O
is ? ? O
the ? ? O
relatively ? ? O
low ? ? O
sensitivity ? ? O
. ? ? O

Hence 15205047 ? O
, ? ? O
this ? ? O
parameter ? ? O
is ? ? O
not ? ? O
suitable ? ? O
for ? ? O
screening ? ? O
for ? ? O
subjects ? ? O
with ? ? O
alcohol ? ? I-disease
abuse ? ? I-disease
in ? ? O
the ? ? O
general ? ? O
population ? ? O
. ? ? O

As 15205047 ? O
CDT ? ? O
, ? ? O
GGT ? ? O
, ? ? O
and ? ? O
MCV ? ? O
are ? ? O
connected ? ? O
with ? ? O
chronic ? ? O
alcohol ? ? O
consumption ? ? O
by ? ? O
different ? ? O
pathophysiological ? ? O
mechanisms ? ? O
, ? ? O
a ? ? O
combination ? ? O
of ? ? O
these ? ? O
parameters ? ? O
will ? ? O
further ? ? O
improve ? ? O
the ? ? O
diagnostic ? ? O
value ? ? O
. ? ? O

Genetic 18344013 ? O
variants ? ? O
of ? ? O
transferrin ? ? I-gene
in ? ? O
cystic ? ? I-disease
fibrosis ? ? I-disease
. ? ? O

BACKGROUND 18344013 ? O
: ? ? O
Genetic ? ? O
polymorphism ? ? O
of ? ? O
serum ? ? O
transferrin ? ? I-gene
( ? ? O
Tf ? ? I-gene
) ? ? O
was ? ? O
studied ? ? O
in ? ? O
order ? ? O
to ? ? O
differentiate ? ? O
between ? ? O
protein ? ? O
genetic ? ? O
variants ? ? O
and ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
, ? ? O
further ? ? O
focusing ? ? O
on ? ? O
unusual ? ? O
findings ? ? O
. ? ? O

METHODS 18344013 ? O
: ? ? O
Screening ? ? O
of ? ? O
Tf ? ? I-gene
hypoglycosylation ? ? I-disease
was ? ? O
carried ? ? O
out ? ? O
by ? ? O
isoelectric ? ? O
focusing ? ? O
with ? ? O
direct ? ? O
immunofixation ? ? O
and ? ? O
Coomassie ? ? O
blue ? ? O
staining ? ? O
in ? ? O
100 ? ? O
healthy ? ? O
controls ? ? O
and ? ? O
a ? ? O
group ? ? O
of ? ? O
1247 ? ? O
patients ? ? O
with ? ? O
various ? ? O
symptoms ? ? O
and ? ? O
diagnoses ? ? O
. ? ? O

RESULTS 18344013 ? O
: ? ? O
Of ? ? O
the ? ? O
seven ? ? O
different ? ? O
genotypes ? ? O
detected ? ? O
, ? ? O
a ? ? O
significantly ? ? O
higher ? ? O
( ? ? O
p ? ? O
= ? ? O
0.004 ? ? O
) ? ? O
frequency ? ? O
of ? ? O
Tf ? ? I-gene
C1C2 ? ? I-gene
was ? ? O
found ? ? O
among ? ? O
92 ? ? O
patients ? ? O
with ? ? O
cystic ? ? I-disease
fibrosis ? ? I-disease
; ? ? O
only ? ? O
the ? ? O
most ? ? O
severe ? ? O
DF508 ? ? I-gene
mutation ? ? O
( ? ? O
in ? ? O
either ? ? O
homozygous ? ? O
or ? ? O
heterozygous ? ? O
form ? ? O
) ? ? O
was ? ? O
regularly ? ? O
present ? ? O
in ? ? O
the ? ? O
carriers ? ? O
of ? ? O
this ? ? O
Tf ? ? I-gene
genotype ? ? O
, ? ? O
in ? ? O
contrast ? ? O
to ? ? O
those ? ? O
with ? ? O
the ? ? O
Tf ? ? I-gene
C1C1 ? ? I-gene
variant ? ? O
. ? ? O

CONCLUSIONS 18344013 ? O
: ? ? O
Association ? ? O
of ? ? O
Tf ? ? I-gene
C2 ? ? I-gene
allele ? ? O
with ? ? O
various ? ? O
malfunctions ? ? O
has ? ? O
been ? ? O
noticed ? ? O
before ? ? O
, ? ? O
but ? ? O
is ? ? O
so ? ? O
far ? ? O
unresolved ? ? O
. ? ? O

This 18344013 ? O
is ? ? O
the ? ? O
a ? ? O
report ? ? O
on ? ? O
increased ? ? O
frequency ? ? O
of ? ? O
Tf ? ? I-gene
C1C2 ? ? I-gene
genotype ? ? O
found ? ? O
in ? ? O
cystic ? ? I-disease
fibrosis ? ? I-disease
. ? ? O

Analysis 18344013 ? O
of ? ? O
larger ? ? O
samples ? ? O
and ? ? O
independent ? ? O
confirmation ? ? O
of ? ? O
our ? ? O
results ? ? O
are ? ? O
needed ? ? O
. ? ? O

Different 18485644 ? O
neuroradiological ? ? O
findings ? ? O
during ? ? O
two ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
a ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

Congenital 18485644 ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
are ? ? O
the ? ? O
most ? ? O
common ? ? O
type ? ? O
of ? ? O
CDG ? ? I-disease
and ? ? O
are ? ? O
characterized ? ? O
by ? ? O
liver ? ? I-disease
dysfunction ? ? I-disease
, ? ? O
coagulation ? ? I-disease
disorders ? ? I-disease
, ? ? O
mental ? ? I-disease
retardation ? ? I-disease
, ? ? O
hypotonia ? ? I-disease
, ? ? O
cerebellar ? ? I-disease
dysfunction ? ? I-disease
, ? ? O
polyneuropathy ? ? I-disease
, ? ? O
seizures ? ? I-disease
, ? ? O
and ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
. ? ? O

Stroke-like 18485644 ? I-disease
episodes ? ? I-disease
occur ? ? O
in ? ? O
40-55 ? ? O
% ? ? O
of ? ? O
cases ? ? O
, ? ? O
but ? ? O
their ? ? O
etiology ? ? O
is ? ? O
not ? ? O
fully ? ? O
understood ? ? O
. ? ? O

Although 18485644 ? O
it ? ? O
has ? ? O
been ? ? O
stated ? ? O
that ? ? O
an ? ? O
epileptic ? ? I-disease
process ? ? I-disease
may ? ? O
cause ? ? O
the ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
, ? ? O
there ? ? O
is ? ? O
no ? ? O
clear ? ? O
evidence ? ? O
of ? ? O
ischemic ? ? I-disease
stroke ? ? I-disease
. ? ? O

Here 18485644 ? O
, ? ? O
we ? ? O
describe ? ? O
two ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
CDG ? ? I-disease
. ? ? O

We 18485644 ? O
performed ? ? O
radiological ? ? O
studies ? ? O
during ? ? O
each ? ? O
episode ? ? O
and ? ? O
obtained ? ? O
two ? ? O
distinct ? ? O
magnetic ? ? O
resonance ? ? O
imaging ? ? O
( ? ? O
MRI ? ? O
) ? ? O
findings ? ? O
: ? ? O
one ? ? O
revealed ? ? O
an ? ? O
ischemic ? ? I-disease
stroke ? ? I-disease
, ? ? O
and ? ? O
the ? ? O
other ? ? O
demonstrated ? ? O
marked ? ? I-disease
edema ? ? I-disease
followed ? ? O
by ? ? O
focal ? ? I-disease
necrosis ? ? I-disease
. ? ? O

This 18485644 ? O
is ? ? O
the ? ? O
first ? ? O
direct ? ? O
evidence ? ? O
of ? ? O
ischemic ? ? I-disease
stroke ? ? I-disease
, ? ? O
and ? ? O
we ? ? O
report ? ? O
that ? ? O
another ? ? O
process ? ? O
may ? ? O
affect ? ? O
the ? ? O
etiology ? ? O
in ? ? O
the ? ? O
same ? ? O
patient ? ? O
. ? ? O

Congenital 19396570 ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
: ? ? O
heterogeneity ? ? O
in ? ? O
the ? ? O
clinical ? ? O
presentation ? ? O
from ? ? O
multivisceral ? ? I-disease
failure ? ? I-disease
to ? ? O
hyperinsulinaemic ? ? I-disease
hypoglycaemia ? ? I-disease
as ? ? O
leading ? ? O
symptoms ? ? O
in ? ? O
three ? ? O
infants ? ? O
with ? ? O
phosphomannomutase ? ? I-disease
deficiency ? ? I-disease
. ? ? O

We 19396570 ? O
describe ? ? O
three ? ? O
patients ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? I-disease
CDG ? ? I-disease
) ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
, ? ? O
all ? ? O
of ? ? O
whom ? ? O
had ? ? O
persistent ? ? O
hyperinsulinaemic ? ? I-disease
hypoglycaemia ? ? I-disease
responding ? ? O
to ? ? O
diazoxide ? ? I-treatment
therapy ? ? O
as ? ? O
a ? ? O
common ? ? O
feature ? ? O
. ? ? O

The 19396570 ? O
first ? ? O
patient ? ? O
, ? ? O
an ? ? O
infant ? ? O
girl ? ? O
, ? ? O
presented ? ? O
with ? ? O
recurrent ? ? I-disease
vomiting ? ? I-disease
, ? ? O
failure ? ? I-disease
to ? ? I-disease
thrive ? ? I-disease
, ? ? O
liver ? ? I-disease
impairment ? ? I-disease
, ? ? O
hypothyroidism ? ? I-disease
and ? ? O
a ? ? O
pericardial ? ? I-disease
effusion ? ? I-disease
. ? ? O

The 19396570 ? O
second ? ? O
patient ? ? O
, ? ? O
also ? ? O
female ? ? O
, ? ? O
had ? ? O
a ? ? O
milder ? ? O
disease ? ? O
with ? ? O
single ? ? O
organ ? ? O
involvement ? ? O
, ? ? O
presenting ? ? O
as ? ? O
isolated ? ? O
hyperinsulinaemic ? ? I-disease
hypoglycaemia ? ? I-disease
, ? ? O
not ? ? O
associated ? ? O
with ? ? O
any ? ? O
cognitive ? ? I-disease
impairment ? ? I-disease
. ? ? O

The 19396570 ? O
third ? ? O
patient ? ? O
, ? ? O
a ? ? O
boy ? ? O
presented ? ? O
with ? ? O
multi-organ ? ? O
manifestations ? ? O
including ? ? O
congenital ? ? I-disease
hypothyroidism ? ? I-disease
, ? ? O
persistent ? ? I-disease
hyperinsulinaemic ? ? I-disease
hypoglycaemia ? ? I-disease
, ? ? O
coagulopathy ? ? I-disease
, ? ? O
olivopontocerebellar ? ? I-disease
hypoplasia ? ? I-disease
and ? ? O
recurrent ? ? I-disease
pancreatitis ? ? I-disease
. ? ? O

All 19396570 ? O
three ? ? O
patients ? ? O
had ? ? O
a ? ? O
type ? ? I-gene
1 ? ? I-gene
serum ? ? I-gene
transferrin ? ? I-gene
isoform ? ? I-gene
pattern ? ? O
, ? ? O
and ? ? O
were ? ? O
subsequently ? ? O
found ? ? O
to ? ? O
have ? ? O
low ? ? I-disease
phosphomannomutase ? ? I-disease
activity ? ? I-disease
, ? ? O
confirming ? ? O
the ? ? O
diagnosis ? ? O
of ? ? O
CDG ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

Our 19396570 ? O
findings ? ? O
emphasize ? ? O
that ? ? O
CDG ? ? I-disease
should ? ? O
be ? ? O
considered ? ? O
as ? ? O
a ? ? O
differential ? ? O
diagnosis ? ? O
in ? ? O
patients ? ? O
with ? ? O
persistent ? ? O
hyperinsulinaemic ? ? I-disease
hypoglycaemia ? ? I-disease
and ? ? O
that ? ? O
it ? ? O
may ? ? O
even ? ? O
occasionally ? ? O
be ? ? O
the ? ? O
leading ? ? O
symptom ? ? O
in ? ? O
CDG ? ? I-disease
Ia ? ? I-disease
. ? ? O

Potent 21539312 ? O
, ? ? O
selective ? ? O
, ? ? O
and ? ? O
orally ? ? O
available ? ? O
benzoisothiazolone ? ? I-treatment
phosphomannose ? ? I-treatment
isomerase ? ? I-treatment
inhibitors ? ? I-treatment
as ? ? O
probes ? ? O
for ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
Ia ? ? I-disease
. ? ? O

We 21539312 ? O
report ? ? O
the ? ? O
discovery ? ? O
and ? ? O
validation ? ? O
of ? ? O
a ? ? O
series ? ? O
of ? ? O
benzoisothiazolones ? ? I-treatment
as ? ? O
potent ? ? O
inhibitors ? ? O
of ? ? O
phosphomannose ? ? I-gene
isomerase ? ? I-gene
( ? ? O
PMI ? ? I-gene
) ? ? O
, ? ? O
an ? ? O
enzyme ? ? O
that ? ? O
converts ? ? O
mannose-6-phosphate ? ? I-gene
( ? ? O
Man-6-P ? ? I-gene
) ? ? O
into ? ? O
fructose-6-phosphate ? ? I-gene
( ? ? O
Fru-6-P ? ? I-gene
) ? ? O
and ? ? O
, ? ? O
more ? ? O
importantly ? ? O
, ? ? O
competes ? ? O
with ? ? O
phosphomannomutase ? ? I-gene
2 ? ? I-gene
( ? ? O
PMM2 ? ? I-gene
) ? ? O
for ? ? O
Man-6-P ? ? I-gene
, ? ? O
diverting ? ? O
this ? ? O
substrate ? ? O
from ? ? O
critical ? ? O
protein ? ? O
glycosylation ? ? O
events ? ? O
. ? ? O

In 21539312 ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-treatment
, ? ? O
PMM2 ? ? I-gene
activity ? ? O
is ? ? O
compromised ? ? O
; ? ? O
thus ? ? O
, ? ? O
PMI ? ? I-treatment
inhibition ? ? I-treatment
is ? ? O
a ? ? O
potential ? ? O
strategy ? ? O
for ? ? O
the ? ? O
development ? ? O
of ? ? O
therapeutics ? ? O
. ? ? O

High-throughput 21539312 ? O
screening ? ? O
( ? ? O
HTS ? ? O
) ? ? O
and ? ? O
subsequent ? ? O
chemical ? ? O
optimization ? ? O
led ? ? O
to ? ? O
the ? ? O
identification ? ? O
of ? ? O
a ? ? O
novel ? ? O
class ? ? O
of ? ? O
benzoisothiazolones ? ? I-treatment
as ? ? O
potent ? ? O
PMI ? ? I-treatment
inhibitors ? ? I-treatment
having ? ? O
little ? ? O
or ? ? O
no ? ? O
PMM2 ? ? I-treatment
inhibition ? ? I-treatment
. ? ? O

Two 21539312 ? O
complementary ? ? O
synthetic ? ? O
routes ? ? O
were ? ? O
developed ? ? O
, ? ? O
enabling ? ? O
the ? ? O
critical ? ? O
structural ? ? O
requirements ? ? O
for ? ? O
activity ? ? O
to ? ? O
be ? ? O
determined ? ? O
, ? ? O
and ? ? O
the ? ? O
compounds ? ? O
were ? ? O
subsequently ? ? O
profiled ? ? O
in ? ? O
biochemical ? ? O
and ? ? O
cellular ? ? O
assays ? ? O
to ? ? O
assess ? ? O
efficacy ? ? O
. ? ? O

The 21539312 ? O
most ? ? O
promising ? ? O
compounds ? ? O
were ? ? O
also ? ? O
profiled ? ? O
for ? ? O
bioavailability ? ? O
parameters ? ? O
, ? ? O
including ? ? O
metabolic ? ? O
stability ? ? O
, ? ? O
plasma ? ? O
stability ? ? O
, ? ? O
and ? ? O
permeability ? ? O
. ? ? O

The 21539312 ? O
pharmacokinetic ? ? O
profile ? ? O
of ? ? O
a ? ? O
representative ? ? O
of ? ? O
this ? ? O
series ? ? O
( ? ? O
compound ? ? I-treatment
19 ? ? I-treatment
; ? ? O
ML089 ? ? I-treatment
) ? ? O
was ? ? O
also ? ? O
assessed ? ? O
, ? ? O
demonstrating ? ? O
the ? ? O
potential ? ? O
of ? ? O
this ? ? O
series ? ? O
for ? ? O
in ? ? O
vivo ? ? O
efficacy ? ? O
when ? ? O
dosed ? ? O
orally ? ? O
in ? ? O
disease ? ? O
models ? ? O
. ? ? O

Distinct 21960674 ? O
features ? ? O
of ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
IIx ? ? I-disease
in ? ? O
Kuwait ? ? O
: ? ? O
a ? ? O
case ? ? O
report ? ? O
. ? ? O

Congenital 21960674 ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
are ? ? O
a ? ? O
rare ? ? O
but ? ? O
complex ? ? O
group ? ? O
of ? ? O
inborn ? ? O
metabolic ? ? I-disease
diseases ? ? I-disease
that ? ? O
result ? ? O
in ? ? O
carbohydrate-deficient ? ? I-disease
glycoproteins ? ? I-disease
. ? ? O

Biochemical 21960674 ? O
and ? ? O
clinical ? ? O
features ? ? O
of ? ? O
both ? ? O
types ? ? O
I ? ? O
and ? ? O
II ? ? O
of ? ? O
this ? ? O
group ? ? O
of ? ? O
disorders ? ? O
have ? ? O
been ? ? O
well ? ? O
characterized ? ? O
and ? ? O
reported ? ? O
from ? ? O
various ? ? O
parts ? ? O
of ? ? O
the ? ? O
world ? ? O
except ? ? O
the ? ? O
Middle ? ? O
East ? ? O
. ? ? O

The 21960674 ? O
authors ? ? O
describe ? ? O
a ? ? O
patient ? ? O
with ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
IIx ? ? I-disease
who ? ? O
presented ? ? O
with ? ? O
psychomotor ? ? I-disease
retardation ? ? I-disease
, ? ? O
development ? ? I-disease
delay ? ? I-disease
, ? ? O
hypotonia ? ? I-disease
, ? ? O
and ? ? O
hepatomegaly ? ? I-disease
. ? ? O

Computed 21960674 ? O
tomography ? ? O
scan ? ? O
of ? ? O
the ? ? O
liver ? ? O
showed ? ? O
multiple ? ? I-disease
hepatic ? ? I-disease
focal ? ? I-disease
lesions ? ? I-disease
, ? ? O
and ? ? O
magnetic ? ? O
resonance ? ? O
imaging ? ? O
revealed ? ? O
mild ? ? O
brain ? ? I-disease
and ? ? I-disease
corpus ? ? I-disease
callosum ? ? I-disease
atrophy ? ? I-disease
. ? ? O

This 21960674 ? O
is ? ? O
the ? ? O
first ? ? O
report ? ? O
of ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
IIx ? ? I-disease
from ? ? O
Kuwait ? ? O
that ? ? O
shows ? ? O
its ? ? O
prevalence ? ? O
and ? ? O
distinct ? ? O
features ? ? O
in ? ? O
the ? ? O
Middle ? ? O
East ? ? O
. ? ? O

Approaches 22983704 ? O
to ? ? O
homozygosity ? ? O
mapping ? ? O
and ? ? O
exome ? ? O
sequencing ? ? O
for ? ? O
the ? ? O
identification ? ? O
of ? ? O
novel ? ? O
types ? ? O
of ? ? O
CDG ? ? I-disease
. ? ? O

In 22983704 ? O
the ? ? O
past ? ? O
decade ? ? O
, ? ? O
the ? ? O
identification ? ? O
of ? ? O
most ? ? O
genes ? ? O
involved ? ? O
in ? ? O
Congenital ? ? I-disease
Disorders ? ? I-disease
of ? ? I-disease
Glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
( ? ? O
type ? ? I-disease
I ? ? I-disease
) ? ? O
was ? ? O
achieved ? ? O
by ? ? O
a ? ? O
combination ? ? O
of ? ? O
biochemical ? ? O
, ? ? O
cell ? ? O
biological ? ? O
and ? ? O
glycobiological ? ? O
investigations ? ? O
. ? ? O

This 22983704 ? O
has ? ? O
been ? ? O
truly ? ? O
successful ? ? O
for ? ? O
CDG-I ? ? I-disease
, ? ? O
because ? ? O
the ? ? O
candidate ? ? O
genes ? ? O
could ? ? O
be ? ? O
selected ? ? O
on ? ? O
the ? ? O
basis ? ? O
of ? ? O
the ? ? O
homology ? ? O
of ? ? O
the ? ? O
synthetic ? ? O
pathway ? ? O
of ? ? O
the ? ? O
dolichol ? ? O
linked ? ? O
oligosaccharide ? ? O
in ? ? O
human ? ? O
and ? ? O
yeast ? ? O
. ? ? O

On 22983704 ? O
the ? ? O
contrary ? ? O
, ? ? O
only ? ? O
a ? ? O
few ? ? O
CDG-II ? ? I-disease
defects ? ? O
were ? ? O
elucidated ? ? O
, ? ? O
be ? ? O
it ? ? O
that ? ? O
some ? ? O
of ? ? O
the ? ? O
discoveries ? ? O
represent ? ? O
wonderful ? ? O
breakthroughs ? ? O
, ? ? O
like ? ? O
e.g ? ? O
, ? ? O
the ? ? O
identification ? ? O
of ? ? O
the ? ? O
COG ? ? I-gene
defects ? ? O
. ? ? O

In 22983704 ? O
general ? ? O
, ? ? O
many ? ? O
rare ? ? O
genetic ? ? O
defects ? ? O
have ? ? O
been ? ? O
identified ? ? O
by ? ? O
positional ? ? O
cloning ? ? O
. ? ? O

However 22983704 ? O
, ? ? O
only ? ? O
a ? ? O
few ? ? O
types ? ? O
of ? ? O
CDG ? ? I-disease
have ? ? O
effectively ? ? O
been ? ? O
elucidated ? ? O
by ? ? O
linkage ? ? O
analysis ? ? O
and ? ? O
so-called ? ? O
reverse ? ? O
genetics ? ? O
. ? ? O

The 22983704 ? O
reason ? ? O
is ? ? O
that ? ? O
the ? ? O
families ? ? O
were ? ? O
relatively ? ? O
small ? ? O
and ? ? O
could-except ? ? O
for ? ? O
CDG-PMM2-not ? ? I-disease
be ? ? O
pooled ? ? O
for ? ? O
analysis ? ? O
. ? ? O

Hence 22983704 ? O
, ? ? O
a ? ? O
large ? ? O
number ? ? O
of ? ? O
CDG ? ? I-disease
cases ? ? O
has ? ? O
long ? ? O
remained ? ? O
unsolved ? ? O
because ? ? O
the ? ? O
search ? ? O
for ? ? O
the ? ? O
culprit ? ? O
gene ? ? O
was ? ? O
very ? ? O
laborious ? ? O
, ? ? O
due ? ? O
to ? ? O
the ? ? O
heterogeneous ? ? O
phenotype ? ? O
and ? ? O
the ? ? O
myriad ? ? O
of ? ? O
candidate ? ? O
defects ? ? O
. ? ? O

This 22983704 ? O
has ? ? O
changed ? ? O
when ? ? O
homozygosity ? ? O
mapping ? ? O
came ? ? O
of ? ? O
age ? ? O
, ? ? O
because ? ? O
it ? ? O
could ? ? O
be ? ? O
applied ? ? O
to ? ? O
small ? ? O
( ? ? O
consanguineous ? ? O
) ? ? O
families ? ? O
. ? ? O

Many 22983704 ? O
novel ? ? O
CDG ? ? I-disease
genes ? ? O
have ? ? O
been ? ? O
discovered ? ? O
in ? ? O
this ? ? O
way ? ? O
. ? ? O

But 22983704 ? O
the ? ? O
best ? ? O
has ? ? O
yet ? ? O
to ? ? O
come ? ? O
: ? ? O
what ? ? O
we ? ? O
are ? ? O
currently ? ? O
witnessing ? ? O
, ? ? O
is ? ? O
an ? ? O
explosion ? ? O
of ? ? O
novel ? ? O
CDG ? ? I-disease
defects ? ? O
, ? ? O
thanks ? ? O
to ? ? O
exome ? ? O
sequencing ? ? O
: ? ? O
seven ? ? O
novel ? ? O
types ? ? O
were ? ? O
published ? ? O
over ? ? O
a ? ? O
period ? ? O
of ? ? O
only ? ? O
two ? ? O
years ? ? O
. ? ? O

It 22983704 ? O
is ? ? O
expected ? ? O
that ? ? O
exome ? ? O
sequencing ? ? O
will ? ? O
soon ? ? O
become ? ? O
a ? ? O
diagnostic ? ? O
tool ? ? O
, ? ? O
that ? ? O
will ? ? O
continuously ? ? O
uncover ? ? O
new ? ? O
facets ? ? O
of ? ? O
this ? ? O
fascinating ? ? O
group ? ? O
of ? ? O
diseases ? ? O
. ? ? O

Expression 23471032 ? O
of ? ? O
the ? ? O
sialyltransferase ? ? I-gene
, ? ? O
ST3Gal4 ? ? I-gene
, ? ? O
impacts ? ? O
cardiac ? ? I-disease
voltage-gated ? ? I-disease
sodium ? ? I-disease
channel ? ? I-disease
activity ? ? I-disease
, ? ? O
refractory ? ? I-disease
period ? ? I-disease
and ? ? O
ventricular ? ? I-disease
conduction ? ? I-disease
. ? ? O

The 23471032 ? O
sequential ? ? O
glycosylation ? ? I-disease
process ? ? O
typically ? ? O
ends ? ? O
with ? ? O
sialic ? ? I-treatment
acid ? ? I-treatment
residues ? ? O
added ? ? O
through ? ? O
trans-Golgi ? ? I-gene
sialyltransferase ? ? I-gene
activity ? ? I-gene
. ? ? O

Individuals 23471032 ? O
afflicted ? ? O
with ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
often ? ? O
have ? ? O
reduced ? ? I-disease
glycoprotein ? ? I-disease
sialylation ? ? I-disease
and ? ? O
present ? ? O
with ? ? O
multi-system ? ? O
symptoms ? ? O
including ? ? O
hypotonia ? ? I-disease
, ? ? O
seizures ? ? I-disease
, ? ? O
arrhythmia ? ? I-disease
and ? ? O
cardiomyopathy ? ? I-disease
. ? ? O

Cardiac 23471032 ? I-disease
voltage-gated ? ? I-disease
Na ? ? I-disease
( ? ? I-disease
+ ? ? I-disease
) ? ? I-disease
channel ? ? I-disease
( ? ? I-disease
Nav ? ? I-disease
) ? ? I-disease
activity ? ? I-disease
can ? ? O
be ? ? O
influenced ? ? O
by ? ? O
sialic ? ? I-treatment
acids ? ? I-treatment
likely ? ? O
contributing ? ? O
to ? ? O
an ? ? O
external ? ? O
surface ? ? O
potential ? ? O
causing ? ? O
channels ? ? O
to ? ? O
gate ? ? O
at ? ? O
less ? ? O
depolarized ? ? O
voltages ? ? O
. ? ? O

Here 23471032 ? O
, ? ? O
a ? ? O
possible ? ? O
pathophysiological ? ? O
role ? ? O
for ? ? O
reduced ? ? I-disease
sialylation ? ? I-disease
is ? ? O
investigated ? ? O
by ? ? O
questioning ? ? O
the ? ? O
impact ? ? O
of ? ? O
gene ? ? O
deletion ? ? O
of ? ? O
the ? ? O
uniformly ? ? O
expressed ? ? O
beta-galactoside ? ? I-gene
alpha-2,3-sialyltransferase ? ? I-gene
4 ? ? I-gene
( ? ? O
ST3Gal4 ? ? I-gene
) ? ? O
on ? ? O
cardiac ? ? I-disease
Nav ? ? I-disease
activity ? ? I-disease
, ? ? O
cellular ? ? I-disease
refractory ? ? I-disease
period ? ? I-disease
and ? ? O
ventricular ? ? I-disease
conduction ? ? I-disease
. ? ? O

Whole-cell 23471032 ? O
patch-clamp ? ? O
experiments ? ? O
showed ? ? O
that ? ? O
ventricular ? ? I-disease
Nav ? ? I-disease
from ? ? O
ST3Gal4 ? ? I-gene
deficient ? ? O
mice ? ? O
( ? ? O
ST3Gal4 ? ? I-gene
( ? ? O
- ? ? O
/ ? ? O
- ? ? O
) ? ? O
) ? ? O
gated ? ? O
at ? ? O
more ? ? O
depolarized ? ? O
potentials ? ? O
, ? ? O
inactivated ? ? O
more ? ? O
slowly ? ? O
and ? ? O
recovered ? ? O
from ? ? O
fast ? ? O
inactivation ? ? O
more ? ? O
rapidly ? ? O
than ? ? O
WT ? ? O
controls ? ? O
. ? ? O

Current-clamp 23471032 ? O
recordings ? ? O
indicated ? ? O
a ? ? O
20 ? ? O
% ? ? O
increase ? ? O
in ? ? O
time ? ? O
to ? ? O
action ? ? O
potential ? ? O
peak ? ? O
and ? ? O
a ? ? O
30ms ? ? O
decrease ? ? O
in ? ? O
ST3Gal4 ? ? I-gene
( ? ? O
- ? ? O
/ ? ? O
- ? ? O
) ? ? O
myocyte ? ? O
refractory ? ? O
period ? ? O
, ? ? O
concurrent ? ? O
with ? ? O
increased ? ? O
Nav ? ? O
recovery ? ? O
rate ? ? O
. ? ? O

Nav 23471032 ? O
expression ? ? O
, ? ? O
distribution ? ? O
and ? ? O
maximal ? ? O
Na ? ? O
( ? ? O
+ ? ? O
) ? ? O
current ? ? O
levels ? ? O
were ? ? O
unaffected ? ? O
by ? ? O
ST3Gal4 ? ? I-gene
expression ? ? O
, ? ? O
indicating ? ? O
that ? ? O
reduced ? ? I-disease
sialylation ? ? I-disease
does ? ? O
not ? ? O
impact ? ? O
Nav ? ? O
surface ? ? O
expression ? ? O
and ? ? O
distribution ? ? O
. ? ? O

However 23471032 ? O
, ? ? O
enzymatic ? ? I-disease
desialylation ? ? I-disease
suggested ? ? O
that ? ? O
ST3Gal4 ? ? I-gene
( ? ? O
- ? ? O
/ ? ? O
- ? ? O
) ? ? O
ventricular ? ? O
Nav ? ? O
are ? ? O
less ? ? O
sialylated ? ? O
. ? ? O

Consistent 23471032 ? O
with ? ? O
the ? ? O
shortened ? ? O
myocyte ? ? O
refractory ? ? O
period ? ? O
, ? ? O
epicardial ? ? O
conduction ? ? O
experiments ? ? O
using ? ? O
optical ? ? O
mapping ? ? O
techniques ? ? O
demonstrated ? ? O
a ? ? O
27 ? ? O
% ? ? O
reduction ? ? O
in ? ? O
minimum ? ? O
ventricular ? ? O
refractory ? ? O
period ? ? O
and ? ? O
increased ? ? O
susceptibility ? ? O
to ? ? O
arrhythmias ? ? I-disease
in ? ? O
ST3Gal4 ? ? I-gene
( ? ? O
- ? ? O
/ ? ? O
- ? ? O
) ? ? O
ventricles ? ? O
. ? ? O

Thus 23471032 ? O
, ? ? O
deletion ? ? O
of ? ? O
a ? ? O
single ? ? O
sialyltransferase ? ? I-gene
significantly ? ? O
impacts ? ? O
ventricular ? ? O
myocyte ? ? O
electrical ? ? O
signaling ? ? O
. ? ? O

These 23471032 ? O
studies ? ? O
offer ? ? O
insight ? ? O
into ? ? O
diseases ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
that ? ? O
are ? ? O
often ? ? O
associated ? ? O
with ? ? O
pathological ? ? I-disease
changes ? ? I-disease
in ? ? I-disease
excitability ? ? I-disease
and ? ? O
highlight ? ? O
the ? ? O
importance ? ? O
of ? ? O
glycosylation ? ? I-disease
in ? ? O
cardiac ? ? O
physiology ? ? O
. ? ? O

Socio-emotional 23733602 ? I-disease
Problems ? ? I-disease
in ? ? O
Children ? ? O
with ? ? O
CDG ? ? I-disease
. ? ? O

BACKGROUND 23733602 ? O
: ? ? O
Congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
form ? ? O
a ? ? O
group ? ? O
of ? ? O
inherited ? ? O
metabolic ? ? O
diseases ? ? O
. ? ? O

Although 23733602 ? O
the ? ? O
clinical ? ? O
presentation ? ? O
shows ? ? O
extreme ? ? O
variability ? ? O
, ? ? O
the ? ? O
nervous ? ? O
system ? ? O
is ? ? O
frequently ? ? O
affected ? ? O
. ? ? O

Several 23733602 ? O
parents ? ? O
of ? ? O
our ? ? O
patients ? ? O
diagnosed ? ? O
with ? ? O
CDG ? ? I-disease
reported ? ? O
behavioral ? ? I-disease
problems ? ? I-disease
, ? ? O
including ? ? O
mood ? ? I-disease
swings ? ? I-disease
, ? ? O
depressive ? ? I-disease
behavior ? ? I-disease
, ? ? O
and ? ? O
anxiety ? ? I-disease
. ? ? O

This 23733602 ? O
raised ? ? O
the ? ? O
question ? ? O
whether ? ? O
patients ? ? O
with ? ? O
CDG ? ? I-disease
have ? ? O
an ? ? O
increased ? ? O
risk ? ? O
for ? ? O
socio-emotional ? ? I-disease
problems ? ? I-disease
. ? ? O

METHODS 23733602 ? O
: ? ? O
We ? ? O
evaluated ? ? O
18 ? ? O
children ? ? O
with ? ? O
confirmed ? ? O
CDG ? ? I-disease
. ? ? O

The 23733602 ? O
Child ? ? O
Behavior ? ? O
Checklist ? ? O
( ? ? O
CBCL ? ? O
) ? ? O
was ? ? O
used ? ? O
to ? ? O
screen ? ? O
for ? ? O
socio-emotional ? ? I-disease
problems ? ? I-disease
. ? ? O

To 23733602 ? O
determine ? ? O
the ? ? O
disease ? ? O
progression ? ? O
and ? ? O
severity ? ? O
in ? ? O
CDG ? ? I-disease
, ? ? O
the ? ? O
Nijmegen ? ? O
Paediatric ? ? O
CDG ? ? I-disease
Rating ? ? O
Scale ? ? O
( ? ? O
NPCRS ? ? O
) ? ? O
was ? ? O
used ? ? O
. ? ? O

RESULTS 23733602 ? O
were ? ? O
compared ? ? O
to ? ? O
`` ? ? O
norm ? ? O
scores ? ? O
'' ? ? O
and ? ? O
to ? ? O
children ? ? O
with ? ? O
mitochondrial ? ? I-disease
disorders ? ? I-disease
and ? ? O
children ? ? O
with ? ? O
other ? ? O
chronic ? ? I-disease
metabolic ? ? I-disease
disorders ? ? I-disease
with ? ? O
multisystem ? ? I-disease
involvement ? ? I-disease
. ? ? O

RESULTS 23733602 ? O
: ? ? O
RESULTS ? ? O
showed ? ? O
a ? ? O
high ? ? O
prevalence ? ? O
of ? ? O
socio-emotional ? ? I-disease
problems ? ? I-disease
in ? ? O
children ? ? O
with ? ? O
CDG ? ? I-disease
. ? ? O

Mean 23733602 ? O
total ? ? O
scores ? ? O
, ? ? O
scores ? ? O
on ? ? O
withdrawn ? ? I-disease
/ ? ? I-disease
depressed ? ? I-disease
behavior ? ? I-disease
, ? ? O
social ? ? I-disease
problems ? ? I-disease
, ? ? O
and ? ? O
somatic ? ? I-disease
complaints ? ? I-disease
were ? ? O
significantly ? ? O
increased ? ? O
. ? ? O

More 23733602 ? O
than ? ? O
two ? ? O
thirds ? ? O
of ? ? O
our ? ? O
CDG ? ? I-disease
patients ? ? O
have ? ? O
abnormal ? ? O
scores ? ? O
on ? ? O
CBCL ? ? O
. ? ? O

The 23733602 ? O
mean ? ? O
score ? ? O
on ? ? O
social ? ? I-disease
problems ? ? I-disease
was ? ? O
significantly ? ? O
higher ? ? O
compared ? ? O
to ? ? O
our ? ? O
two ? ? O
control ? ? O
groups ? ? O
of ? ? O
patients ? ? O
with ? ? O
other ? ? O
chronic ? ? I-disease
metabolic ? ? I-disease
disorders ? ? I-disease
. ? ? O

CONCLUSIONS 23733602 ? O
: ? ? O
Patients ? ? O
with ? ? O
CDG ? ? I-disease
have ? ? O
an ? ? O
increased ? ? O
risk ? ? O
of ? ? O
developing ? ? O
socio-emotional ? ? I-disease
problems ? ? I-disease
. ? ? O

A 23733602 ? O
standard ? ? O
screening ? ? O
for ? ? O
psychological ? ? I-disease
problems ? ? I-disease
is ? ? O
recommended ? ? O
for ? ? O
the ? ? O
early ? ? O
detection ? ? O
of ? ? O
psychological ? ? I-disease
problems ? ? I-disease
in ? ? O
CDG ? ? I-disease
patients ? ? O
. ? ? O

Initial 25192236 ? O
diagnosis ? ? O
of ? ? O
the ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
PMM2-CDG ? ? I-disease
( ? ? O
CDG1a ? ? I-disease
) ? ? O
in ? ? O
a ? ? O
4-year-old ? ? O
girl ? ? O
after ? ? O
neurosurgical ? ? O
intervention ? ? O
for ? ? O
cerebral ? ? I-disease
hemorrhage ? ? I-disease
. ? ? O

The 25192236 ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
characterized ? ? O
by ? ? O
a ? ? O
deficiency ? ? I-disease
of ? ? I-disease
phosphomannomutase ? ? I-disease
2 ? ? I-disease
( ? ? O
PMM2-CDG ? ? I-disease
) ? ? O
is ? ? O
the ? ? O
most ? ? O
common ? ? O
variant ? ? O
of ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
. ? ? O

Besides 25192236 ? O
typical ? ? O
clinical ? ? O
features ? ? O
, ? ? O
such ? ? O
as ? ? O
dysmorphism ? ? I-disease
and ? ? O
abnormal ? ? I-disease
body ? ? I-disease
fat ? ? I-disease
distribution ? ? I-disease
, ? ? O
coagulation ? ? I-disease
abnormities ? ? I-disease
often ? ? O
lead ? ? O
to ? ? O
thromboembolic ? ? I-disease
and ? ? O
hemorrhagic ? ? I-disease
events ? ? O
in ? ? O
these ? ? O
patients ? ? O
. ? ? O

However 25192236 ? O
, ? ? O
only ? ? O
2 ? ? O
cases ? ? O
of ? ? O
intracerebral ? ? I-disease
bleeding ? ? I-disease
in ? ? O
patients ? ? O
with ? ? O
PMM2-CDG ? ? I-gene
have ? ? O
been ? ? O
described ? ? O
so ? ? O
far ? ? O
. ? ? O

A 25192236 ? O
4-year-old ? ? O
girl ? ? O
who ? ? O
initially ? ? O
presented ? ? O
with ? ? O
symptoms ? ? O
resulting ? ? O
from ? ? O
raised ? ? I-disease
intracranial ? ? I-disease
pressure ? ? I-disease
underwent ? ? O
acute ? ? O
neurosurgical ? ? O
intervention ? ? O
for ? ? O
intracranial ? ? I-disease
hemorrhage ? ? I-disease
. ? ? O

The 25192236 ? O
differential ? ? O
diagnoses ? ? O
after ? ? O
MRI ? ? O
included ? ? O
arteriovenous ? ? I-disease
malformation ? ? I-disease
and ? ? O
intraparenchymal ? ? I-disease
brain ? ? I-disease
tumor ? ? I-disease
. ? ? O

However 25192236 ? O
, ? ? O
clinical ? ? O
investigations ? ? O
promoted ? ? O
the ? ? O
diagnosis ? ? O
of ? ? O
PMM2-CDG ? ? I-disease
, ? ? O
which ? ? O
was ? ? O
supported ? ? O
further ? ? O
by ? ? O
neuropathological ? ? O
findings ? ? O
and ? ? O
finally ? ? O
confirmed ? ? O
by ? ? O
isoelectric ? ? O
focusing ? ? O
and ? ? O
mutational ? ? O
analysis ? ? O
. ? ? O

No 25192236 ? O
major ? ? O
complications ? ? O
or ? ? O
neurological ? ? I-disease
deficits ? ? I-disease
were ? ? O
evident ? ? O
after ? ? O
surgery ? ? O
, ? ? O
and ? ? O
the ? ? O
patient ? ? O
was ? ? O
able ? ? O
to ? ? O
attend ? ? O
an ? ? O
integrated ? ? O
kindergarten ? ? O
. ? ? O

Unexplained 25192236 ? O
intracranial ? ? I-disease
hemorrhage ? ? I-disease
should ? ? O
raise ? ? O
suspicion ? ? O
of ? ? O
a ? ? O
metabolic ? ? I-disease
disorder ? ? I-disease
and ? ? O
should ? ? O
be ? ? O
discussed ? ? O
with ? ? O
specialists ? ? O
to ? ? O
rule ? ? O
out ? ? O
an ? ? O
orphan ? ? O
disease ? ? O
such ? ? O
as ? ? O
PMM2-CDG ? ? I-disease
. ? ? O

MALDI-TOF 25641685 ? O
MS ? ? O
applied ? ? O
to ? ? O
apoC-III ? ? I-gene
glycoforms ? ? O
of ? ? O
patients ? ? O
with ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
affecting ? ? O
O-glycosylation ? ? I-disease
. ? ? O

Comparison 25641685 ? O
with ? ? O
two-dimensional ? ? O
electrophoresis ? ? O
. ? ? O

PURPOSE 25641685 ? O
: ? ? O
The ? ? O
O-glycan ? ? I-disease
abnormalities ? ? I-disease
accompanying ? ? O
some ? ? O
congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
, ? ? O
namely ? ? O
conserved ? ? I-disease
oligomeric ? ? I-disease
Golgi-congenital ? ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
COG-CDGs ? ? I-disease
) ? ? O
and ? ? O
ATP6V0A2-CDGs ? ? I-disease
, ? ? O
are ? ? O
mainly ? ? O
detected ? ? O
using ? ? O
electrophoresis ? ? O
methods ? ? O
applied ? ? O
to ? ? O
circulating ? ? O
apolipoprotein ? ? I-gene
C-III ? ? I-gene
. ? ? O

The 25641685 ? O
objective ? ? O
of ? ? O
this ? ? O
study ? ? O
was ? ? O
to ? ? O
evaluate ? ? O
the ? ? O
reliability ? ? O
of ? ? O
MALDI-TOF ? ? O
MS ? ? O
of ? ? O
apoC-III ? ? I-gene
for ? ? O
the ? ? O
detection ? ? O
and ? ? O
characterization ? ? O
of ? ? O
CDG-associated ? ? I-disease
O-glycan ? ? I-disease
defects ? ? I-disease
. ? ? O

EXPERIMENTAL 25641685 ? O
DESIGN ? ? O
: ? ? O
plasmas ? ? O
from ? ? O
CDG-negative ? ? I-gene
, ? ? O
COG-CDG ? ? I-gene
, ? ? O
and ? ? O
ATP6V0A2-CDG ? ? I-gene
patients ? ? O
were ? ? O
analyzed ? ? O
and ? ? O
results ? ? O
were ? ? O
compared ? ? O
to ? ? O
those ? ? O
obtained ? ? O
using ? ? O
2DE ? ? O
followed ? ? O
by ? ? O
Western ? ? O
blot ? ? O
. ? ? O

RESULTS 25641685 ? O
: ? ? O
MALDI-TOF ? ? O
of ? ? O
apoC-III ? ? I-gene
allowed ? ? O
to ? ? O
detect ? ? O
various ? ? O
significant ? ? O
O-glycan ? ? I-disease
abnormalities ? ? I-disease
in ? ? O
CDG-patients ? ? I-disease
with ? ? O
emphasis ? ? O
to ? ? O
COG-CDG ? ? I-disease
. ? ? O

Furthermore 25641685 ? O
, ? ? O
in ? ? O
CDG ? ? I-disease
samples ? ? O
, ? ? O
comparison ? ? O
study ? ? O
between ? ? O
2DE ? ? O
and ? ? O
MALDI-TOF ? ? O
showed ? ? O
a ? ? O
particular ? ? O
behavior ? ? O
of ? ? O
monosialylated ? ? I-gene
apoC-III ? ? I-gene
in ? ? O
the ? ? O
mass ? ? O
spectrometer ? ? O
that ? ? O
could ? ? O
be ? ? O
related ? ? O
to ? ? O
an ? ? O
abnormal ? ? I-disease
O-glycan ? ? I-disease
structure ? ? I-disease
. ? ? O

CONCLUSIONS 25641685 ? O
AND ? ? O
CLINICAL ? ? O
RELEVANCE ? ? O
: ? ? O
MALDI-TOF ? ? O
MS ? ? O
appears ? ? O
as ? ? O
a ? ? O
powerful ? ? O
technique ? ? O
for ? ? O
the ? ? O
analysis ? ? O
of ? ? O
apoC-III ? ? I-gene
glycoforms ? ? O
for ? ? O
potential ? ? O
routine ? ? O
screening ? ? O
of ? ? O
COG- ? ? O
and ? ? O
ATP6V0A2-CDGs ? ? I-disease
. ? ? O

